Zengen Inc. Company Profile
Founded in 1999, Zengen Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative products to treat and prevent inflammation and infection through application of its proprietary peptide technologies.
Zengen focuses on the discovery and early-stage development of drug candidates and seeks to establish partnerships with pharmaceutical companies for further development and commercialization of Zengen's peptides. For more information on partnered programs and licensing opportunities.
7049 Owensmouth AvenueSuite 112
United States of America
Phone: (818) 887-8688
Fax: (818) 887-3883
Recently added to the BioPortfolio report store, Vulvovaginal Candidiasis Global Clinical Trials Review, H2, 2014 is a new report from GlobalData published on 2014-12-30. This 72-page report is avail...
Drugs and Medications
Founded in 1999, Zengen Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative products to treat and prevent inflammation and infection through applicat...
More Information about "Zengen Inc." on BioPortfolio
We have published hundreds of Zengen Inc. news stories on BioPortfolio along with dozens of Zengen Inc. Clinical Trials and PubMed Articles about Zengen Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Zengen Inc. Companies in our database. You can also find out about relevant Zengen Inc. Drugs and Medications on this site too.